GLOBAL DOUBLE STANDARDS

James Joyner · Wednesday, July 30, 2003 · No Comments

Robert Kuttner thinks we’re being inconsistent by, on the one hand, exporting low skill jobs to India to take advantage of their lower labor costs but, on the other hand, refusing to import drugs from India produced in violation if US patent and drug approval laws. Well…..no.

It may well be worth reconsidering our drug approval process and the length of patent and copyright protections. But these are separate arguments. A US company can’t reverse engineer a patented product and sell it here, either. Nor can a US company sell drugs that aren’t FDA approved.

FILED UNDER: Economics and Business

None Found

About James Joyner
James Joyner is the publisher of Outside the Beltway and the managing editor of the Atlantic Council. He's a former Army officer, Desert Storm vet, and college professor with a PhD in political science from The University of Alabama. Follow James on Twitter.